N-(2-Oxo-2,3-dihydro-1H-benzo[d]imidazol-5-yl)propionamide

Catalog No.: 
ACSLCC550
CAS No.: 
445410-25-3
Molecular Formula: 
C10H11N3O2
Molecular Weight: 
205.22
N-(2-Oxo-2,3-dihydro-1H-benzo[d]imidazol-5-yl)propionamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$149.00InquiryInquiry
100mg95%$215.00InquiryInquiry
250mg95%$298.00InquiryInquiry
1g95%$701.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(2-Oxo-2,3-dihydro-1H-benzo[d]imidazol-5-yl)propionamide
IUPAC NameN-(2-oxo-2,3-dihydro-1H-benzo[d]imidazol-5-yl)propionamide
Molecular FormulaC10H11N3O2
Molecular Weight205.22
SMILESCCC(NC1=CC=C(NC(N2)=O)C2=C1)=O
InChI KeyVBJWIRGHLZMDOV-UHFFFAOYSA-N
SynonymN-(2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl)pro panamide;Propanamide, N-(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)-
CAS No.445410-25-3

Synthetic Route by SureRoute

1. ACSLCC550 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACJXUZ198 route compound structure diagram
    ACJXUZ19895-23-8In Stock
  4. Then
  5. ACSLCC550 route product structure diagram
    ACSLCC550445410-25-3
Inquiry

2. ACSLCC550 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNRAG148 route compound structure diagram
    ACNRAG14813080-96-1In Stock
  2. Plus
  3. ACJXUZ198 route compound structure diagram
    ACJXUZ19895-23-8In Stock
  4. Then
  5. ACSLCC550 route product structure diagram
    ACSLCC550445410-25-3
Inquiry

3. ACSLCC550 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACADFR680 route compound structure diagram
    ACADFR680137-40-6In Stock
  2. Plus
  3. ACJXUZ198 route compound structure diagram
    ACJXUZ19895-23-8In Stock
  4. Then
  5. ACSLCC550 route product structure diagram
    ACSLCC550445410-25-3
Inquiry

Comments (0)